New Nanotech to Detect Cancer Early

Dr. Joshua Smith is a research scientist and team lead for IBM’s Nanobiotechnology Program. Around forty percent of the population will receive a cancer diagnosis within their lifetime. Accurate early diagnosis drastically increases the survival rate of most cancers. Current methods for diagnosis are invasive, costly, and not reliably accurate. Dr. Joshua Smith and his…